BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26388626)

  • 1. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
    Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
    Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.
    Habeeb R; Al Hafar L; Monem F
    J Infect Dev Ctries; 2021 Dec; 15(12):1917-1922. PubMed ID: 35044951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
    Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease.
    Musacchio JG; Carvalho Mda G; Morais JC; Silva NH; Scheliga A; Romano S; Spector N
    Sao Paulo Med J; 2006 May; 124(3):154-7. PubMed ID: 17119693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.
    Sinha M; Rao CR; Shafiulla M; Appaji L; Bs AK; Sumati BG; Avinash T; Jayshree RS
    Pediatr Hematol Oncol; 2013 Sep; 30(6):537-43. PubMed ID: 23756088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma.
    Pajand O; Pourakbari B; Mahjob F; Aghamohammadi A; Mamishi N; Mamishi S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):10-5. PubMed ID: 21083364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
    Machado AS; Da Silva Robaina MC; Magalhães De Rezende LM; Apa AG; Amoêdo ND; Bacchi CE; Klumb CE
    Leuk Lymphoma; 2010 Jun; 51(6):1020-7. PubMed ID: 20470219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of quantitative analysis of plasma epstein- barr virus DNA in patients of Xinjiang Uygur nationality with Hodgkin's Lymphoma.
    Li X; Yang SE; Guo YQ; Shen MX; Gu L; Zhao GB; Liu W; Xun T; Bai JP
    Asian Pac J Cancer Prev; 2012; 13(12):6379-84. PubMed ID: 23464462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
    Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Leuk Res; 2021 Aug; 107():106607. PubMed ID: 33957372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
    Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
    BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
    Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
    Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
    AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction.
    Wagner HJ; Schläger F; Claviez A; Bucsky P
    Eur J Cancer; 2001 Oct; 37(15):1853-7. PubMed ID: 11576839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
    Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
    Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Br J Haematol; 2000 Oct; 111(1):239-46. PubMed ID: 11091207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
    Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
    Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
    Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
    Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.